• Something wrong with this record ?

Therapeutisches Management eines „kissing nevus“ des Augenlids [Therapeutic management of a kissing nevus of the eyelid]

PJ. Gaca, R. Rejdak, MD. Toro, M. Lewandowicz, A. Kopecky, GM. Somfai, R. Nowak, LM. Heindl

. 2024 ; 121 (2) : 116-122. [pub] 20240102

Language German Country Germany

Document type English Abstract, Journal Article, Review

Persistent link   https://www.medvik.cz/link/bmc24007316

Congenital divided melanocytic nevi of the upper and lower eyelid are rare pigmented changes of the eyelids. These processes are also known as "kissing nevi," "panda nevi," and "split ocular nevi," and were first described by Fuchs in 1919. About 120 cases have been described in the literature so far. Congenital melanocytic nevi are either present at birth (small nevi are already found in about 1% of neonates) or manifest predominantly during the first decade of life. These rare melanocytic changes of the eyelids should be controlled regularly, as malignant transformation can occur. The actual incidence of malignant transformation is highly variable in the literature, ranging from 2 to 40% depending on the duration of follow-up, with an average of 14% for the whole lifetime. Moreover, nevi of the eyelids may be considered cosmetically disturbing and cause functional problems. Therapeutic removal (dermabrasion, cryotherapy, laser therapy, and surgical excision with ophthalmoplastic reconstruction) is rarely medically indicated due to the low risk of malignant transformation. Removal can be performed in cases of secondary amblyopia in ptosis, compression of the lacrimal point, epiphora, or cosmetic desire. Treatment becomes necessary not only in case of suspicious manifestation or impairment of eyelid function, but it also helps to avoid possible bullying at school among children and is recommended at age 4 to 6 (before school age).

Therapeutic management of a kissing nevus of the eyelid

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24007316
003      
CZ-PrNML
005      
20240423155854.0
007      
ta
008      
240412s2024 gw f 000 0|ger||
009      
AR
024    7_
$a 10.1007/s00347-023-01963-w $2 doi
035    __
$a (PubMed)38165419
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a ger
044    __
$a gw
100    1_
$a Gaca, P J $u Zentrum für Augenheilkunde, Medizinische Fakultät und Uniklinik Köln, Universität zu Köln, Kerpener Straße 62, 50937, Köln, Deutschland. piotrjakub.gaca@gmail.com $u Abteilung für Allgemeine Ophthalmologie und Pädiatrische Ophthalmologie, Medizinische Universität Lublin, Lublin, Polen. piotrjakub.gaca@gmail.com $1 https://orcid.org/0000000348778543
245    10
$a Therapeutisches Management eines „kissing nevus“ des Augenlids / $c PJ. Gaca, R. Rejdak, MD. Toro, M. Lewandowicz, A. Kopecky, GM. Somfai, R. Nowak, LM. Heindl
246    31
$a [Therapeutic management of a kissing nevus of the eyelid]
520    9_
$a Congenital divided melanocytic nevi of the upper and lower eyelid are rare pigmented changes of the eyelids. These processes are also known as "kissing nevi," "panda nevi," and "split ocular nevi," and were first described by Fuchs in 1919. About 120 cases have been described in the literature so far. Congenital melanocytic nevi are either present at birth (small nevi are already found in about 1% of neonates) or manifest predominantly during the first decade of life. These rare melanocytic changes of the eyelids should be controlled regularly, as malignant transformation can occur. The actual incidence of malignant transformation is highly variable in the literature, ranging from 2 to 40% depending on the duration of follow-up, with an average of 14% for the whole lifetime. Moreover, nevi of the eyelids may be considered cosmetically disturbing and cause functional problems. Therapeutic removal (dermabrasion, cryotherapy, laser therapy, and surgical excision with ophthalmoplastic reconstruction) is rarely medically indicated due to the low risk of malignant transformation. Removal can be performed in cases of secondary amblyopia in ptosis, compression of the lacrimal point, epiphora, or cosmetic desire. Treatment becomes necessary not only in case of suspicious manifestation or impairment of eyelid function, but it also helps to avoid possible bullying at school among children and is recommended at age 4 to 6 (before school age).
650    _2
$a lidé $7 D006801
650    _2
$a dítě $7 D002648
650    _2
$a novorozenec $7 D007231
650    _2
$a předškolní dítě $7 D002675
650    12
$a pigmentový névus $x chirurgie $7 D009508
650    12
$a epiteloidní a vřetenobuněčný névus $x chirurgie $7 D018332
650    _2
$a oční víčka $x chirurgie $7 D005143
650    12
$a laserová terapie $7 D053685
650    _2
$a nádorová transformace buněk $x patologie $7 D002471
650    12
$a nádory kůže $x chirurgie $7 D012878
655    _2
$a anglický abstrakt $7 D004740
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Rejdak, R $u Abteilung für Allgemeine Ophthalmologie und Pädiatrische Ophthalmologie, Medizinische Universität Lublin, Lublin, Polen
700    1_
$a Toro, M D $u Abteilung für Allgemeine Ophthalmologie und Pädiatrische Ophthalmologie, Medizinische Universität Lublin, Lublin, Polen $u Klinik für Augenheilkunde, Abteilung für öffentliche Gesundheit, Universität Neapel Federico II, Neapel, Italien
700    1_
$a Lewandowicz, M $u Abteilung für onkologische Chirurgie, Multidisziplinäres M. Copernicus Woiwodschaftszentrum für Onkologie und Traumatologie, Lodz, Polen
700    1_
$a Kopecky, A $u Zentrum für Augenheilkunde, Medizinische Fakultät und Uniklinik Köln, Universität zu Köln, Kerpener Straße 62, 50937, Köln, Deutschland $u Klinik für Augenheilkunde, Universitätskrankenhaus Ostrava, Ostrava, Tschechien $u Medizinische Fakultät, Universität Ostrava, Ostrava, Tschechien
700    1_
$a Somfai, G M $u Augenklinik, Stadtspital Zürich, Zürich, Schweiz
700    1_
$a Nowak, R $u Wojskowy Instytut Medyczny, Klinika Okulistyki, Warszawa, Polen
700    1_
$a Heindl, L M $u Zentrum für Augenheilkunde, Medizinische Fakultät und Uniklinik Köln, Universität zu Köln, Kerpener Straße 62, 50937, Köln, Deutschland $u Centrum für Integrierte Onkologie (CIO) Bonn-Düsseldorf-Köln, Köln, Deutschland
773    0_
$w MED00210813 $t Die Ophthalmologie $x 2731-7218 $g Roč. 121, č. 2 (2024), s. 116-122
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38165419 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423155851 $b ABA008
999    __
$a ok $b bmc $g 2081351 $s 1217083
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 121 $c 2 $d 116-122 $e 20240102 $i 2731-7218 $m Die Ophthalmologie $n Ophthalmologie $x MED00210813
LZP    __
$a Pubmed-20240412

Find record

Citation metrics

Archiving options